(Reuters) - BOSTON, July 25 - Genzyme Corp. said on Wednesday that second-quarter earnings rose on higher sales of its drugs for rare and chronic diseases, prompting the biotechnology company to increase its 2007 forecast for the second time this year.
Genzyme's shares rose more than 3 percent in early trading.
Read more at Reuters.com Market News
Genzyme's shares rose more than 3 percent in early trading.
Read more at Reuters.com Market News
No comments:
Post a Comment